US Patent Issued to Beijing Gene MiNK Biotechnology on Oct. 7 for "Antibody targeting B cell maturation antigen and related products thereof and medical applications" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,153, issued on Oct. 7, was assigned to Beijing Gene MiNK Biotechnology Co.LTD (Beijing).

"Antibody targeting B cell maturation antigen and related products thereof and medical applications" was invented by Zhihua Lu (Beijing) and Yongfeng Liu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure belongs to the fields of biotechnology and biological medicine, and specifically relates to an antibody targeting a B cell maturation antigen (BCMA) and related products thereof and medical applications. Specifically, the antibody contains a variable light chain and a variable heavy chain. The variable light chain contains a light cha...